MicroRNAs as molecular biological markers of benign hyperplasia and prostate cancer differentiation

Diagnosis and treatment of prostate cancer (PCа) are associated with the serum level of prostate specific antigen (PSA). However, certain prostate diseases such as benign prostatic hyperplasia (BPH) and prostatitis can also affect PSA levels. The low specificity and sensitivity of PSA leads to a &qu...

Full description

Bibliographic Details
Main Authors: Z. M. Akhokhov, R. S. Ismailov, M. I. Kogan
Format: Article
Language:Russian
Published: State Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian Federation 2023-10-01
Series:Vestnik Urologii
Subjects:
Online Access:https://www.urovest.ru/jour/article/view/760
_version_ 1797272092267249664
author Z. M. Akhokhov
R. S. Ismailov
M. I. Kogan
author_facet Z. M. Akhokhov
R. S. Ismailov
M. I. Kogan
author_sort Z. M. Akhokhov
collection DOAJ
description Diagnosis and treatment of prostate cancer (PCа) are associated with the serum level of prostate specific antigen (PSA). However, certain prostate diseases such as benign prostatic hyperplasia (BPH) and prostatitis can also affect PSA levels. The low specificity and sensitivity of PSA leads to a "unnecessary" prostate biopsy, which certainly makes this diagnostic method a controversial screening test. As a result, the discovery of new non-invasive molecular biological markers are necessary for the diagnosis, treatment, surveillance and prognosis of patients with diseases of prostate. This review aims to evaluate the "benefit" of miRNAs as molecular biological markers of BPH and PCa differentiation.
first_indexed 2024-03-07T14:23:28Z
format Article
id doaj.art-a0ce2708c5af4b9e96d3fc9047dd162a
institution Directory Open Access Journal
issn 2308-6424
language Russian
last_indexed 2024-03-07T14:23:28Z
publishDate 2023-10-01
publisher State Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian Federation
record_format Article
series Vestnik Urologii
spelling doaj.art-a0ce2708c5af4b9e96d3fc9047dd162a2024-03-06T08:56:06ZrusState Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian FederationVestnik Urologii2308-64242023-10-011139810710.21886/2308-6424-2023-11-3-98-107470MicroRNAs as molecular biological markers of benign hyperplasia and prostate cancer differentiationZ. M. Akhokhov0R. S. Ismailov1M. I. Kogan2Rostov State Medical UniversityRostov State Medical UniversityRostov State Medical UniversityDiagnosis and treatment of prostate cancer (PCа) are associated with the serum level of prostate specific antigen (PSA). However, certain prostate diseases such as benign prostatic hyperplasia (BPH) and prostatitis can also affect PSA levels. The low specificity and sensitivity of PSA leads to a "unnecessary" prostate biopsy, which certainly makes this diagnostic method a controversial screening test. As a result, the discovery of new non-invasive molecular biological markers are necessary for the diagnosis, treatment, surveillance and prognosis of patients with diseases of prostate. This review aims to evaluate the "benefit" of miRNAs as molecular biological markers of BPH and PCa differentiation.https://www.urovest.ru/jour/article/view/760mirnabenign prostatic hyperplasiaprostate cancerlower urinary tract symptomsprostate specific antigenmolecular biological markersribonucleic acidreview
spellingShingle Z. M. Akhokhov
R. S. Ismailov
M. I. Kogan
MicroRNAs as molecular biological markers of benign hyperplasia and prostate cancer differentiation
Vestnik Urologii
mirna
benign prostatic hyperplasia
prostate cancer
lower urinary tract symptoms
prostate specific antigen
molecular biological markers
ribonucleic acid
review
title MicroRNAs as molecular biological markers of benign hyperplasia and prostate cancer differentiation
title_full MicroRNAs as molecular biological markers of benign hyperplasia and prostate cancer differentiation
title_fullStr MicroRNAs as molecular biological markers of benign hyperplasia and prostate cancer differentiation
title_full_unstemmed MicroRNAs as molecular biological markers of benign hyperplasia and prostate cancer differentiation
title_short MicroRNAs as molecular biological markers of benign hyperplasia and prostate cancer differentiation
title_sort micrornas as molecular biological markers of benign hyperplasia and prostate cancer differentiation
topic mirna
benign prostatic hyperplasia
prostate cancer
lower urinary tract symptoms
prostate specific antigen
molecular biological markers
ribonucleic acid
review
url https://www.urovest.ru/jour/article/view/760
work_keys_str_mv AT zmakhokhov micrornasasmolecularbiologicalmarkersofbenignhyperplasiaandprostatecancerdifferentiation
AT rsismailov micrornasasmolecularbiologicalmarkersofbenignhyperplasiaandprostatecancerdifferentiation
AT mikogan micrornasasmolecularbiologicalmarkersofbenignhyperplasiaandprostatecancerdifferentiation